Latest news with #MGMMedicalCollege
Time of India
21 hours ago
- Health
- Time of India
Active Covid count reaches 32 with four new cases
Indore: Indore continues to witness a surge in Covid-19 infections, with four new cases reported on Monday, bringing the total number of active cases in the district to 32. According to District Epidemiologist Dr Anshul Mishra, all four new patients are male residents of Indore, aged 30, 32, 48, and 57 years. They have no recent travel history, are currently stable, and are undergoing home isolation. Dr Mishra noted that most patients are presenting with mild symptoms. So far in the current calendar year, Indore reported two Covid-19 related fatalities. The first was a 74-year-old woman from Indore who passed away approximately one and a half months ago while receiving treatment at a private hospital. The second was a 44-year-old woman from Khargone, who delivered a baby a few days prior at MTH Hospital and tragically died on Friday during treatment at MRTB Hospital after testing positive for Covid-19. Dr Mishra stated that samples for suspected cases are currently collected at MRTB Hospital until 2 PM, with testing conducted at MGM Medical College's lab. For the remaining hours, or if doctors at MRTB Hospital do not classify a case as 'suspected,' individuals must rely on private labs and hospitals for diagnosis. This highlights that Indore's govt healthcare infrastructure remains under-equipped for basic public diagnostic access. TNN
Time of India
01-06-2025
- Health
- Time of India
MGM successfully treats blood cancer patient with CAR T-Cell therapy
Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so. Tired of too many ads? go ad free now "The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy. Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them. In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said. Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others. Tired of too many ads? go ad free now Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so. "The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy. Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them. In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said. Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others.
